INHIBITON OF NF-κB ACTIVATION DURING ISCHEMIA REDUCES HEPATIC ISCHEMIA/REPERFUSION INJURY IN RATS
Authors:
- Kazumi KasajimaKKKazumi Kasajima
- Nobuko SengaNSNobuko Senga
- 1 January 2005
- journal article
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 30 (2) , 103-110
Abstract
The aim of this study was to determine whether nuclear factor-kappaB (NF-kappaB) inhibitors are efficient against hepatic ischemia/reperfusion (I/R) injury. We previously demonstrated that xanthine oxidase-derived reactive oxygen species activate NF-kappaB during ischemia. However, the role of NF-kappaB activation during ischemia in post-reperfusion injury remains unclear. Therefore, while we examined the effects of NF-kappaB inhibitors, sulfasalazine and pyrrolidinedithiocarbamate on hepatic I/R injury using a rat lobar hepatic I/R model, we estimated the relationship between NF-kappaB activation during ischemia and following hepatic damage caused by reperfusion. The portal vein and the hepatic artery were clamped for 1 hr followed by reperfusion for up to 24 hr. NF-kappaB activation was determined by Western blot analysis. NF-kappaB activation was observed in the ischemic lobe of the liver, and the activation was prevented by pre-administration with NF-kappaB inhibitors. Although the serum ALT level, hepatic MPO activity and BSP clearance, as an index of hepatic injury, were increased after reperfusion, the increase was attenuated by pre-administration with NF-kappaB inhibitors. These findings suggest that NF-kappaB activation during ischemia is relevant to hepatic I/R injury. Moreover, we first showed that pre-administration with NF-kappaB inhibitors is effective against hepatic I/R injury.Keywords
This publication has 20 references indexed in Scilit:
- Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancerJournal of Clinical Investigation, 2001
- Series Introduction: The transcription factor NF-κB and human diseaseJournal of Clinical Investigation, 2001
- NF-κB: a key role in inflammatory diseasesJournal of Clinical Investigation, 2001
- Xanthine Oxidase-Derived Reactive Oxygen Species Activate Nuclear Factor Kappa B During Hepatic Ischemia in RatsThe Japanese Journal of Pharmacology, 2000
- Xanthine Oxidase Inhibition Attenuates Kupffer Cell Production of Neutrophil Chemoattractant Following Ischemia–Reperfusion in Rat LiverHepatology, 1998
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- HYPOXIA, BUT NOT REOXYGENATION, INDUCES INTERLEUKIN 6 GENE EXPRESSION THROUGH NF-??B ACTIVATION1Transplantation, 1997
- Prostaglandin E1 abrogates early reductive stress and zone-specific paradoxical oxidative injury in hypoperfused rat liver.Journal of Clinical Investigation, 1994
- PRESERVATION AND REPERFUSION INJURIES IN LIVER ALLOGRAFTSTransplantation, 1992
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970